resourceId,resourceName,resourceType,observationText,observationType,observationPhase,observationTime,observationTimeUnits,doi
7d71c2b4-a7c5-4ced-bb45-eb98bfe42025,B6;129S2-Trp53tm1Tyj Nf1tm1Tyj/J,['Animal Model'],"The NPcis mice are a compound heterozygous model with mutations in both the Nf1 and Trp53 genes on a C57BL/6 background, generated by breeding male NPcis mice with wildtype females as homozygous knockouts are embryonically lethal.","['Genotype', 'Breeding']",,,,https://doi.org/10.3390/genes11070762
7d71c2b4-a7c5-4ced-bb45-eb98bfe42025,B6;129S2-Trp53tm1Tyj Nf1tm1Tyj/J,['Animal Model'],"The NPcis mice develop malignant peripheral nerve sheath tumors (MPNSTs) with high penetrance, mimicking the human disease neurofibromatosis type 1 (NF1).","['Disease Susceptibility', 'Tumor Incidence']",,,,https://doi.org/10.1158/1078-0432.CCR-13-1740
7d71c2b4-a7c5-4ced-bb45-eb98bfe42025,B6;129S2-Trp53tm1Tyj Nf1tm1Tyj/J,['Animal Model'],"Preneoplastic lesions are consistently observed in NPcis mice by 3 months of age, which progress to symptomatic MPNSTs requiring euthanasia by 7-9 months due to neurological symptoms in 100% of mice.","['Tumor Progression', 'Neurological Symptoms']",juvenile,3,months,https://doi.org/10.1158/1078-0432.CCR-13-1740
7d71c2b4-a7c5-4ced-bb45-eb98bfe42025,B6;129S2-Trp53tm1Tyj Nf1tm1Tyj/J,['Animal Model'],The NPcis model exhibits allelic imbalance and genetic modifiers on chromosomes 15 and 19 that influence MPNST susceptibility.,"['Genomics', 'Disease Susceptibility']",,,,https://doi.org/10.1158/0008-5472.CAN-05-1480
7d71c2b4-a7c5-4ced-bb45-eb98bfe42025,B6;129S2-Trp53tm1Tyj Nf1tm1Tyj/J,['Animal Model'],"The NPcis mice show stunted growth and reduced body weight/size compared to wildtype littermates, with the growth defects stabilizing at around 50% of normal by a few days after birth.","['Growth rate', 'Body weight']",postnatal,3,days,https://doi.org/10.1101/gad.862101
7d71c2b4-a7c5-4ced-bb45-eb98bfe42025,B6;129S2-Trp53tm1Tyj Nf1tm1Tyj/J,['Animal Model'],The NPcis mice exhibited allelic imbalance and genetic modifiers on chromosomes 15 and 19 that influenced malignant peripheral nerve sheath tumor (MPNST) susceptibility when backcrossed to different strains.,"['Genomics', 'Disease Susceptibility']",,,,https://doi.org/10.1158/0008-5472.CAN-05-1480
7d71c2b4-a7c5-4ced-bb45-eb98bfe42025,B6;129S2-Trp53tm1Tyj Nf1tm1Tyj/J,['Animal Model'],"Homozygous Nf1/Trp53 knockout mice are embryonically lethal, so the NPcis model is maintained by breeding heterozygous males with wildtype females.","['Breeding', 'Viability']",prenatal,,,https://doi.org/10.3390/genes11070762
7d71c2b4-a7c5-4ced-bb45-eb98bfe42025,B6;129S2-Trp53tm1Tyj Nf1tm1Tyj/J,['Animal Model'],NPcis mice exhibited a higher incidence of malignant peripheral nerve sheath tumors (MPNSTs) when inheriting the mutant Nf1 and Trp53 alleles paternally compared to maternally.,"['Tumor Incidence', 'Parental Effects']",,,,https://doi.org/10.1007/s00335-009-9179-4
